Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Etanercept Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Etanercept Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Etanercept Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Etanercept Market Size Growth Rate by Type
    • 1.4.2 Benepali
    • 1.4.3 Enbrel
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Etanercept Market Size Growth Rate by Application
    • 1.5.2 Arthritis
    • 1.5.3 Psoriasis
    • 1.5.4 Spondylitis
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Etanercept Market Size, Estimates and Forecasts
    • 2.1.1 Global Etanercept Revenue 2015-2026
    • 2.1.2 Global Etanercept Sales 2015-2026
  • 2.2 Global Etanercept, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Etanercept Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Etanercept Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Etanercept Competitor Landscape by Players

  • 3.1 Etanercept Sales by Manufacturers
    • 3.1.1 Etanercept Sales by Manufacturers (2015-2020)
    • 3.1.2 Etanercept Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Etanercept Revenue by Manufacturers
    • 3.2.1 Etanercept Revenue by Manufacturers (2015-2020)
    • 3.2.2 Etanercept Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Etanercept Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Etanercept Revenue in 2019
    • 3.2.5 Global Etanercept Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Etanercept Price by Manufacturers
  • 3.4 Etanercept Manufacturing Base Distribution, Product Types
    • 3.4.1 Etanercept Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Etanercept Product Type
    • 3.4.3 Date of International Manufacturers Enter into Etanercept Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Etanercept Market Size by Type (2015-2020)
    • 4.1.1 Global Etanercept Sales by Type (2015-2020)
    • 4.1.2 Global Etanercept Revenue by Type (2015-2020)
    • 4.1.3 Etanercept Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Etanercept Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Etanercept Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Etanercept Revenue Forecast by Type (2021-2026)
    • 4.2.3 Etanercept Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Etanercept Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Etanercept Market Size by Application (2015-2020)
    • 5.1.1 Global Etanercept Sales by Application (2015-2020)
    • 5.1.2 Global Etanercept Revenue by Application (2015-2020)
    • 5.1.3 Etanercept Price by Application (2015-2020)
  • 5.2 Etanercept Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Etanercept Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Etanercept Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Etanercept Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Etanercept by Country
    • 6.1.1 North America Etanercept Sales by Country
    • 6.1.2 North America Etanercept Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Etanercept Market Facts & Figures by Type
  • 6.3 North America Etanercept Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Etanercept by Country
    • 7.1.1 Europe Etanercept Sales by Country
    • 7.1.2 Europe Etanercept Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Etanercept Market Facts & Figures by Type
  • 7.3 Europe Etanercept Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Etanercept by Region
    • 8.1.1 Asia Pacific Etanercept Sales by Region
    • 8.1.2 Asia Pacific Etanercept Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Etanercept Market Facts & Figures by Type
  • 8.3 Asia Pacific Etanercept Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Etanercept by Country
    • 9.1.1 Latin America Etanercept Sales by Country
    • 9.1.2 Latin America Etanercept Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Etanercept Market Facts & Figures by Type
  • 9.3 Central & South America Etanercept Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Etanercept by Country
    • 10.1.1 Middle East and Africa Etanercept Sales by Country
    • 10.1.2 Middle East and Africa Etanercept Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Etanercept Market Facts & Figures by Type
  • 10.3 Middle East and Africa Etanercept Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Etanercept Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.2 Takeda
    • 11.2.1 Takeda Corporation Information
    • 11.2.2 Takeda Description and Business Overview
    • 11.2.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Takeda Etanercept Products Offered
    • 11.2.5 Takeda Related Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Description and Business Overview
    • 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Etanercept Products Offered
    • 11.3.5 Johnson & Johnson Related Developments
  • 11.4 GlaxoSmithKline
    • 11.4.1 GlaxoSmithKline Corporation Information
    • 11.4.2 GlaxoSmithKline Description and Business Overview
    • 11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 GlaxoSmithKline Etanercept Products Offered
    • 11.4.5 GlaxoSmithKline Related Developments
  • 11.5 Samsung Bioepis
    • 11.5.1 Samsung Bioepis Corporation Information
    • 11.5.2 Samsung Bioepis Description and Business Overview
    • 11.5.3 Samsung Bioepis Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Samsung Bioepis Etanercept Products Offered
    • 11.5.5 Samsung Bioepis Related Developments
  • 11.6 Roche
    • 11.6.1 Roche Corporation Information
    • 11.6.2 Roche Description and Business Overview
    • 11.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Roche Etanercept Products Offered
    • 11.6.5 Roche Related Developments
  • 11.7 Cipla
    • 11.7.1 Cipla Corporation Information
    • 11.7.2 Cipla Description and Business Overview
    • 11.7.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Cipla Etanercept Products Offered
    • 11.7.5 Cipla Related Developments
  • 11.8 Novartis
    • 11.8.1 Novartis Corporation Information
    • 11.8.2 Novartis Description and Business Overview
    • 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Novartis Etanercept Products Offered
    • 11.8.5 Novartis Related Developments
  • 11.9 Celltrion
    • 11.9.1 Celltrion Corporation Information
    • 11.9.2 Celltrion Description and Business Overview
    • 11.9.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Celltrion Etanercept Products Offered
    • 11.9.5 Celltrion Related Developments
  • 11.10 Immunex
    • 11.10.1 Immunex Corporation Information
    • 11.10.2 Immunex Description and Business Overview
    • 11.10.3 Immunex Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Immunex Etanercept Products Offered
    • 11.10.5 Immunex Related Developments
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Etanercept Products Offered
    • 11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Etanercept Market Estimates and Projections by Region
    • 12.1.1 Global Etanercept Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Etanercept Revenue Forecast by Regions 2021-2026
  • 12.2 North America Etanercept Market Size Forecast (2021-2026)
    • 12.2.1 North America: Etanercept Sales Forecast (2021-2026)
    • 12.2.2 North America: Etanercept Revenue Forecast (2021-2026)
    • 12.2.3 North America: Etanercept Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Etanercept Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Etanercept Sales Forecast (2021-2026)
    • 12.3.2 Europe: Etanercept Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Etanercept Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Etanercept Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Etanercept Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Etanercept Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Etanercept Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Etanercept Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Etanercept Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Etanercept Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Etanercept Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Etanercept Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Etanercept Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Etanercept Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Etanercept Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Etanercept Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Etanercept Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Etanercept market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Etanercept market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Etanercept market is segmented into
    Benepali
    Enbrel
    Others

    Segment by Application, the Etanercept market is segmented into
    Arthritis
    Psoriasis
    Spondylitis

    Regional and Country-level Analysis
    The Etanercept market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Etanercept market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Etanercept Market Share Analysis
    Etanercept market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Etanercept business, the date to enter into the Etanercept market, Etanercept product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer
    Takeda
    Johnson & Johnson
    GlaxoSmithKline
    Samsung Bioepis
    Roche
    Cipla
    Novartis
    Celltrion
    Immunex

    Buy now